Sleep Apnea in Men: The Quiet Epidemic Behind Heart Disease, Hypertension and Burnout

If you are a man over 40 who snores, wakes up tired no matter how long you slept, and has crept into the borderline-hypertensive range at your last two physicals, there is roughly a one-in-three chance you have obstructive sleep apnea. And there is a higher chance still that no one has told you to get tested for it.

Sleep apnea is the most under-diagnosed condition in modern men's health. The American Academy of Sleep Medicine estimates that 24 million American adults have moderate-to-severe obstructive sleep apnea (OSA). Roughly 80 percent of them are undiagnosed. Men are diagnosed at twice the rate of women, but the actual prevalence gap is even wider - women's symptoms tend to be different and atypical, which means men carry the bulk of the disease and the bulk of its consequences.

What Is Actually Happening at Night

OSA is not just snoring. During sleep, the muscles of the upper airway relax. In susceptible men - those with thicker necks, narrower jaws, larger tonsils, more visceral fat around the upper torso - the airway collapses. Breathing stops. The brain registers oxygen drop, partially wakes the body to restart breathing, and then drops back into sleep. This cycle can repeat 30 to 60 times per hour in severe cases.

Each cycle is a small cardiovascular insult. Heart rate spikes. Blood pressure surges. Cortisol rises. The morning blood pressure reading you are getting at your physical is the tail end of an eight-hour stress event.

The Cardiovascular Toll

The data here is unambiguous. Men with untreated severe OSA have:

• 2.4x the risk of stroke compared to matched non-apneic men
• 2.0x the risk of cardiovascular death
• 3.0x the risk of treatment-resistant hypertension
• Roughly 30 percent increase in atrial fibrillation incidence

These are not soft associations. The Wisconsin Sleep Cohort - one of the longest-running prospective sleep studies in medicine - showed that severe OSA at baseline tripled all-cause mortality over 18 years of follow-up. Treatment with CPAP largely abolished the excess risk.

The Symptoms Men Miss

The textbook triad is loud snoring, witnessed apneas, and daytime sleepiness. In practice, plenty of men with OSA do not present that way. The under-diagnosed presentations are:

• Morning headaches - frontal, dull, gone within an hour of waking
• Nocturia - waking 2-3 times per night to urinate (driven by atrial natriuretic peptide release during apneic events)
• Erectile dysfunction - OSA roughly doubles the prevalence of ED in men over 40
• Brain fog and irritability - often blamed on stress, work, or aging
• Treatment-resistant hypertension - blood pressure that won't normalize on two or three medications

If three or more of those apply to you and you are above a BMI of 28, you should be tested. Not eventually. Now.

Why Most Men Are Not Tested

Three reasons dominate. First, primary care visits in the United States now average 13 to 18 minutes - there is no time to take a careful sleep history. Second, sleep is still treated as a lifestyle issue rather than a vital sign. Third, many men actively minimize symptoms because the cultural script is that being tired is a badge of honor and snoring is just something men do.

None of those reasons survive contact with the data. Snoring is a symptom. Tiredness past 40 that does not resolve with seven to eight hours of sleep is a symptom.

How Testing Has Changed

The traditional model - an overnight in-lab polysomnography costing $1,500-$3,000 - is now the second-line option, not the first. Home sleep apnea tests (HSATs) are clinically validated for the screening of moderate-to-severe OSA and cost $200-$400, often covered by insurance. Devices ship to your home, you wear a small sensor on your finger or chest for one to three nights, and the data goes to a sleep physician for interpretation.

The result is an Apnea-Hypopnea Index (AHI), the number of breathing events per hour. The cutoffs:

• AHI under 5 - normal
• AHI 5-15 - mild OSA
• AHI 15-30 - moderate OSA
• AHI over 30 - severe OSA

Anything above 15 should be treated. Below 15 is a clinical judgment based on symptoms, cardiovascular risk, and oxygen desaturation patterns.

Treatment in 2026

CPAP remains the gold standard for moderate-to-severe disease. The newer machines are quieter, smaller, and travel-friendly - the ResMed AirMini is the size of a soda can. Compliance is the historic problem; modern auto-titrating CPAP with heated humidification and connected apps that track usage have pushed long-term adherence above 70 percent in compliant programs.

For men who cannot tolerate CPAP, the alternatives have expanded:

• Oral appliances - mandibular advancement devices, custom-fit by a dentist, effective for mild-to-moderate OSA. Cost: $1,800-$3,000.
• Inspire - implanted hypoglossal nerve stimulator, FDA-approved for moderate-to-severe OSA in patients who fail CPAP. Roughly 70 percent reduction in AHI in qualified candidates.
• GLP-1 agonists - semaglutide and tirzepatide have shown 40-60 percent AHI reduction in obesity-driven OSA in 2024-2025 trial data. The FDA approved tirzepatide specifically for OSA with obesity in late 2024.
• Positional therapy - for the subset of men whose apnea occurs only when sleeping on their back, simple devices that prevent supine sleep can normalize AHI.

What to Do This Week

If the symptoms above describe you:

1. Take the STOP-BANG questionnaire online. Score of 3 or higher means moderate-to-high risk.
2. Request a home sleep apnea test from your primary care physician or order one directly through telemedicine sleep services.
3. If diagnosed, treat. CPAP compliance is the strongest predictor of cardiovascular risk reduction.
4. If overweight, address it. Even 10 percent body weight reduction often drops AHI by 25-30 percent.

The Cultural Shift

The men who get diagnosed early in 2026 are not the ones with the loudest snores. They are the ones whose wives or partners pushed them, or who took an Apple Watch sleep alert seriously, or who connected the dots between their resistant blood pressure and their crushing afternoon fatigue.

Sleep is not optional. Apnea is not character. The treatments work, the testing is cheap, and the consequences of ignoring it - stroke, heart attack, ten years of brain fog - are not abstract. The men who treat sleep apnea live longer and feel better. The men who do not, do not. It really is that simple.